| 1 |
31336317 | UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers. | 2019 Sep 1 |
1 |
| 2 |
22538270 | Effect of gemfibrozil on the metabolism of brivaracetam in vitro and in human subjects. | 2012 Aug |
1 |
| 3 |
16299161 | Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interactions. | 2006 Jan |
2 |
| 4 |
15801938 | Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects. | 2005 Apr |
1 |
| 5 |
16042675 | Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide. | 2005 Aug |
4 |
| 6 |
14650362 | Studies on the interaction between fibrates and statins using human hepatic microsomes. | 2003 |
1 |
| 7 |
14682608 | Interaction between fibrates and statins--metabolic interactions with gemfibrozil. | 2003 |
1 |
| 8 |
12065698 | Effect of albumin and cytosol on enzyme kinetics of tolbutamide hydroxylation and on inhibition of CYP2C9 by gemfibrozil in human liver microsomes. | 2002 Jul |
2 |
| 9 |
11602509 | Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9. | 2001 Nov |
6 |
| 10 |
11719730 | Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepiride. | 2001 Nov |
1 |